LAMA2-related muscular dystrophies (LAMA2-RDs)

Overview

LAMA2-related muscular dystrophy (LAMA2-RD) causes muscle weakness and wasting, and comes in two quite different forms depending on the specific genetic change involved. The severe, early-onset form starts at birth, in infancy, or in early childhood, with delayed motor development, weakness, difficulty walking and breathing problems — most children with this form don't walk independently, and it was previously known as merosin-deficient congenital muscular dystrophy (MDC1A). The milder, late-onset form instead starts later — childhood, adolescence or adulthood — progresses more slowly, and looks more like a limb girdle muscular dystrophy in how it presents; it's also referred to as LGMDR23.

Symptoms

In the severe early-onset form, babies and young children often have low muscle tone and weakness, noticeable as poor head control or delays reaching milestones like sitting and crawling; facial weakness and an enlarged tongue are common and can affect feeding and speech. In the milder late-onset form, weakness is less pronounced and independent walking is usually achieved, though it can be lost later as the body outgrows what the muscles can support.

Breathing muscle weakness is common across both forms and can lead to frequent chest infections and shallow overnight breathing, particularly in the early-onset form, sometimes from a young age; symptoms include daytime sleepiness and morning headaches, and some children need cough-assist devices or non-invasive ventilation. In the severe form, feeding difficulties from weak sucking and swallowing muscles can mean longer mealtimes, trouble gaining weight, and a higher risk of choking or aspiration — a speech and language therapist and dietitian can help considerably here. The milder form may bring only mild chewing or swallowing fatigue.

Joint contractures can be present from birth in the severe form (linked to reduced movement in the womb) or develop later in the milder form; scoliosis and lordosis are common in severe early-onset LAMA2-RD and need specialist spinal monitoring, sometimes with a brace or surgery. Hip dislocation can occur too, reflecting muscle weakness rather than necessarily needing treatment on its own. Brain MRI can show white-matter changes in some people; seizures occur in roughly 3 in 10 cases (more often in severe disease) and can usually be managed with medication, and a minority — again, more often in severe cases — have mild cognitive difficulties. Peripheral nerve involvement (weakness, numbness or tingling, especially in the hands and feet) is possible but generally less prominent than the muscle features.

Inheritance and cause

LAMA2-RD is caused by changes in the LAMA2 gene, which provides instructions for laminin alpha-2 (also called merosin), a protein important for muscle structure. Both copies of the gene are affected, reducing or eliminating laminin production and disrupting normal muscle development — how much laminin is still produced roughly predicts how severe the condition will be. It's inherited in an autosomal recessive pattern: a changed copy is needed from both parents.

Getting a diagnosis

A GP refers to a neurologist, who typically combines a physical exam, family history, blood tests, brain and muscle MRI, genetic testing and sometimes a muscle biopsy. Genetic testing of the LAMA2 gene is the test that confirms the diagnosis.

Management and outlook

There's no specific treatment or cure at present, so care is supportive and anticipatory — getting ahead of likely problems rather than only reacting to them — coordinated by a multidisciplinary team, usually led by a neurologist working alongside specialist therapists, local teams, and (depending on age) a paediatrician.

Respiratory function should be monitored from an early age at a specialist clinic, with overnight sleep studies checking for nocturnal hypoventilation and non-invasive ventilation used to treat it where needed; chest physiotherapy and cough-assist devices can reduce hospital admissions. Nutrition needs early input from speech and language and dietetics teams, with a feeding tube considered if oral intake isn't enough — carers may need training in using one. Bone health is worth monitoring too, since reduced movement increases fracture risk; adequate vitamin D and calcium intake helps. Orthopaedic input manages contractures and scoliosis with splints, braces or, where needed, surgery, always planned carefully around respiratory function. Cardiac problems are uncommon in LAMA2-RD, but monitoring is still recommended, particularly as someone gets older.